Skip to main content

Table 1 Demographics and patient characteristics

From: Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment

Characteristics

MRSA pneumonia n = 134 (%)

Non-MRSA pneumonia n = 134 (%)

p value

Demographics

   

Age [median (IQR)]

82 (71.5, 89)

75.5 (62, 85)

0.0002

Male

67 (50)

62 (46)

0.62

Residence prior to admission

   

  Home

35 (26)

110 (82)

< 0.0001

  SNF

98 (73)

23 (17)

< 0.0001

  Other hospital

1 (0.7)

1 (0.7)

1

APACHE II [median (IQR)]

15 (11,20)

10 (7,13)

<0.0001

Comorbid conditions

   

Cardiovascular diseasea

92 (69)

84 (63)

0.37

Diabetes

44 (33)

26 (19)

<0.0001

Cerebrovascular accident (CVA)

41 (31)

9 (7)

<0.0001

Liver diseaseb

6 (4)

4 (3)

0.74

Renal diseasec

22 (16)

8 (6)

0.011

Pulmonary diseased

47 (35)

39 (29)

0.24

Malignancy

21 (16)

14 (10)

0.37

≥3 comorbid conditions

86 (64)

40 (30)

<0.0001

Healthcare exposure history

   

History of MRSA infection

27 (20)

1 (0.7)

<0.0001

History of MRSA pneumonia

14 (10)

0

<0.0001

Prior healthcare exposure (within 90 days)

120 (90)

50 (37)

<0.0001

Prior antibiotic exposure (within 90 days)

70 (52)

23 (17)

<0.0001

Days since last antibiotic given [median (IQR)]

24 (7,41)

7 (0,32)

0.629

Prior history of pneumonia within 1 year

56 (42)

16 (12)

<0.0001

Presence of feeding tube

67 (50)

15 (11)

<0.0001

Presence of feeding tube plus history of CVA

26 (19)

4 (3)

<0.0001

Clinical presentation

   

Presence of other infections on admission

55 (41)

13 (10)

<0.0001

Admission of intensive care units

63 (47)

18 (13)

<0.0001

Sepsis requiring vasopressor support

45 (34)

8 (6)

<0.0001

Need for mechanical ventilation

47 (35)

14 (10)

<0.0001

PSI class IV or V

123 (92)

71 (53)

<0.0001

  1. NOTE: SNF = skilled nursing facility; PSI = Pneumonia Severity Index; APACHE = Acute Physiology and Chronic Health Evaluation; IQR = interquartile range; aHypertension, congestive heart failure, prior myocardial infarction, coronary artery disease; bTotal bilirubin >2.5 mg/dL; cScr >2, Chronic Kidney Disease stage 3 or worse; dChronic obstructive pulmonary disease, emphysema, asthma.
  2. Fisher’s exact or Chi-square test done for categorical variables; p value < 0.05 denotes significance.
  3. Wilcoxon-Mann–Whitney test done for continuous variables, p value < 0.05 denotes significance.